HighTower Advisors »

Briacell Therapeutics Corp shares owned by HighTower Advisors

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $93k 16k 5.85
2023-09-30 $99k 16k 6.23

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)

View all positions for HighTower Advisors

Top funds holding Briacell Therapeutics Corp

Lynwood Capital Management
Torno Capital
Redmond Asset Management
K.J. Harrison & Partners
Bank Of Montreal
Onyx Bridge Wealth Group
Summit Trail Advisors
Citadel Advisors
Royal Bank of Canada
Bank of America Corporation
HighTower Advisors
TD Waterhouse Canada
Concord Wealth Partners
National Bank Of Canada /fi/
UBS Group

View all funds holding Briacell Therapeutics Corp